ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1529

Trabecular Bone Score in Early Rheumatoid Arthritis

Eulalia Armengol1, Helena Borrell Paños1, Joan Miquel Nolla1, Javier Narváez2 and Carmen Gomez Vaquero1, 1Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid Arthritis (RA) is associated with low bone mass and increased risk of fragility fractures that are related to patient characteristics, treatments and disease activity.

Trabecular Bone Score (TBS) is a new gray-level texture measurement derived from lumbar spine DXA images, independent of bone mineral density (BMD).

In early RA patients, to quantify TBS and its determinants. 

Methods:

From an early RA unit, we selected all the patients who had been prospectively followed from the disease onset according to a predefined protocol, based on a tight control strategy, and had at least a bone densitometry available to calculate TBS. Four patients were excluded because of a body mass index (BMI) greater than 35 kg/m2, since TBS is not reliable in those cases. The study variables were: 1) Demographics: age, sex, body mass index (BMI); 2) RA history: duration, RF, ACPA; 3) Disease activity: DAS28 and CRP; 4) Disability: HAQ; 5) RA treatment; 6) Spine and proximal femur BMD; and 7) TBS.

Results:

We included 170 patients (116 female) with a mean age of 54 ± 14 years and a BMI of 27 ± 4.5 kg/m2. Sixty-seven percent of the patients had RF+ and 60% had ACPA + (mean title: 330 ± 524 U/L). At diagnosis, mean DAS28 was 5.77 ± 1.31; CRP was 26 ± 39.3 mg/L; and HAQ, 1.500 ± 0.654.

Mean BMD in lumbar spine was 0.967 ± 0.162 g/cm2; in femoral neck, 0.779 ± 0.218 g/cm2; and in total femur was 0.952 ± 0.143 g/cm2. Forty-nine percent of the patients had a normal BMD, 34% had osteopenia and 17% had osteoporosis, according to WHO diagnostic classification. Mean TBS was 1.345 ± 0.123. Fifty-two percent of the patients had normal bone microarchitecture, 35% had partially degraded microarchitecture and 13% had degraded microarchitecture. Ten-year probability of having a major osteoporotic fracture, calculated by combining TBS and WHO categories according to data of Hans D et al* and expressed according to the system of the Canadian Association of Radiologists and Osteoporosis Canada (CAROC), was low (< 10%) in 78% of the patients, medium (10-20%) in 16% and high (>20%) in 6%.

In the multivariate analysis, TBS correlated with age (r: -0.50), BMI (r: -0.50), CRP (r: -0.15) and BMD at lumbar spine (r: 0.34). These variables accounted for 51% of the variability of TBS (Regression line: TBS: 1.583 – (0.003 x age) – (0.013 x BMI) + (0.273 x LS BMD)). TBS did not correlate with other study variables.

Conclusion:

Almost half of early RA patients have a deterioration of bone microarchitecture assessed by TBS. In these patients, TBS is very dependent on age, BMI and BMD at lumbar spine. Other disease variables are not related to TBS.

*Hans D. J Bone Miner Res 2011; 26: 2762-9.


Disclosure: E. Armengol, None; H. Borrell Paños, None; J. M. Nolla, None; J. Narváez, None; C. Gomez Vaquero, None.

To cite this abstract in AMA style:

Armengol E, Borrell Paños H, Nolla JM, Narváez J, Gomez Vaquero C. Trabecular Bone Score in Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/trabecular-bone-score-in-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trabecular-bone-score-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology